Powered by Google TranslateTranslate
Original text
Rate this translation
Your feedback will be used to help improve Google Translate
Latest Press Releases
View all
TimeHeadline
1m agoCommvault Announces Fourth Quarter Fiscal 2026 Financial Results
1m agoRamsey Theory Group CEO Dan Herbatschek Warns Wall Street’s AI Boom Faces an ROI Reckoning as Big Tech Earnings Week Begins
2m agoMarsh and Formula 1® Announce Official Multi-Year Partnership
2m agoNexera: KeepZone AI Receives Official Authorization to Introduce Advanced Fuel Tank Structural Survivability System in the Gulf Region
2m agoPing An Reports Steady 7.6% Growth in Operating Profit Attributable to Shareholders of the Parent Company in Q1 2026, Life & Health NBV Increases 20.8% YoY
Lenz Therapeutics Inc logo

Lenz Therapeutics Inc

About

Lenz Therapeutics Inc (NASDAQ:LENZ) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 20 2026
LENZ Therapeutics Announces Submission of Marketing Authorization Application to the Medicines and Healthcare products Regulatory Agency for VIZZ® for the Treatment of Presbyopia in the United Kingdom
Mar 24 2026
LENZ Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights
Mar 17 2026
LENZ Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights on March 24, 2026
Mar 10 2026
LENZ Therapeutics Announces Submission of Marketing Authorization Application to European Medicines Agency for VIZZ® for the Treatment of Presbyopia
Jan 14 2026
LENZ Therapeutics and Sarah Jessica Parker announce the launch of “Make it VIZZable”, the VIZZ consumer campaign

Community Chat

Ask AI

6ix6ix